These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31652847)

  • 1. In-Vitro Subtype-Specific Modulation of HIV-1 Trans-Activator of Transcription (Tat) on RNAi Silencing Suppressor Activity and Cell Death.
    Ronsard L; Yousif AS; Ramesh J; Sumi N; Gorman M; Ramachandran VG; Banerjea AC
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31652847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1.
    Hayes AM; Qian S; Yu L; Boris-Lawrie K
    Retrovirology; 2011 May; 8():36. PubMed ID: 21569500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments.
    Williams ME; Zulu SS; Stein DJ; Joska JA; Naudé PJW
    Neurobiol Dis; 2020 Mar; 136():104701. PubMed ID: 31837421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes.
    Rustanti L; Jin H; Lor M; Lin MH; Rawle DJ; Harrich D
    Virol J; 2017 Mar; 14(1):52. PubMed ID: 28288662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation and function of the HIV-1 Tat protein.
    Spector C; Mele AR; Wigdahl B; Nonnemacher MR
    Med Microbiol Immunol; 2019 Apr; 208(2):131-169. PubMed ID: 30834965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ebola virus VP35 protein is a suppressor of RNA silencing.
    Haasnoot J; de Vries W; Geutjes EJ; Prins M; de Haan P; Berkhout B
    PLoS Pathog; 2007 Jun; 3(6):e86. PubMed ID: 17590081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat.
    Schnettler E; de Vries W; Hemmes H; Haasnoot J; Kormelink R; Goldbach R; Berkhout B
    EMBO Rep; 2009 Mar; 10(3):258-63. PubMed ID: 19218918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Tat protein: Is Tat-C much trickier than Tat-B?
    Johri MK; Sharma N; Singh SK
    J Med Virol; 2015 Aug; 87(8):1334-43. PubMed ID: 25879536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription.
    Ivanov A; Lin X; Ammosova T; Ilatovskiy AV; Kumari N; Lassiter H; Afangbedji N; Niu X; Petukhov MG; Nekhai S
    Retrovirology; 2018 May; 15(1):39. PubMed ID: 29792216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine rich short linear motif of HIV-1 regulatory proteins inhibits dicer dependent RNA interference.
    Ponia SS; Arora S; Kumar B; Banerjea AC
    Retrovirology; 2013 Sep; 10():97. PubMed ID: 24025624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
    Mousseau G; Valente ST
    Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.
    Zhao X; Qian L; Zhou D; Qi D; Liu C; Kong X
    Virol Sin; 2016 Jun; 31(3):199-206. PubMed ID: 27007880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between viral Tat protein and c-Jun transcription factor in controlling LTR promoter activity in different human immunodeficiency virus type I subtypes.
    van der Sluis RM; Derking R; Breidel S; Speijer D; Berkhout B; Jeeninga RE
    J Gen Virol; 2014 Apr; 95(Pt 4):968-979. PubMed ID: 24447950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1.
    Qian S; Zhong X; Yu L; Ding B; de Haan P; Boris-Lawrie K
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):605-10. PubMed ID: 19122141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 57th amino acid conveys the differential subcellular localization of human immunodeficiency virus-1 Tat derived from subtype B and C.
    Zhao X; Qian L; Qi D; Zhou D; Shen W; Liu Y; Liu C; Kong X
    Virus Genes; 2016 Apr; 52(2):179-88. PubMed ID: 26832332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Approach for HIV-1 Replication Inhibition: Assessment of Different siRNAs Targeting Tat and Nef Genes to Effectively Suppress their Expression.
    Rahimi P; Aghasadeghi MR; Arefian E; Mobarakeh VI; Kamalzare S; SajadianFard FS; Amiran MR
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
    Liang C; Wainberg MA
    AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND.
    Marino J; Maubert ME; Mele AR; Spector C; Wigdahl B; Nonnemacher MR
    Cell Mol Life Sci; 2020 Dec; 77(24):5079-5099. PubMed ID: 32577796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
    Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
    RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.